QUIDEL CORPORATION (NASDAQ:QDEL) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.
announcing the financial results for its first>quarter ended
March 31, 2017>and will hold an earnings conference call at 2:00
p.m., Pacific Time, on April 24, 2017>to discuss such results. A
copy of the press release is attached as Exhibit 99.1 to this
current report on Form 8-K.
exhibit attached hereto, is being furnished and shall not be deemed
filed for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of such
section. The information in this current report on Form 8-K shall
not be incorporated by reference into any registration statement or
other document to the Securities Act of 1933, as amended, except as
expressly set forth by specific reference in such filing.
|
|
|
|
|
|
|
|
(d) Exhibits.
|
|||
|
|
The following exhibit is furnished with this current
report on Form 8-K: |
|||
|
|
|
|||
|
Exhibit Number
|
Description of Exhibit
|
|||
|
|
|
|
|
|
|
99.1
|
Press release, dated April 24, 2017, reporting Quidel
Corporation’s financial results for its first quarter ended March 31, 2017. |
|||
|
|
|
|
|
|
About QUIDEL CORPORATION (NASDAQ:QDEL)
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including autoimmune diseases, bone health and thyroid diseases. It provides diagnostic testing solutions under various brand names, including Quidel, QuickVue+ and Thyretain. QUIDEL CORPORATION (NASDAQ:QDEL) Recent Trading Information
QUIDEL CORPORATION (NASDAQ:QDEL) closed its last trading session down -0.06 at 23.50 with 130,818 shares trading hands.
